Image
copyright Gerald & Buff Corsi/Visuals Unlimited, Inc.
|
The town of Kaltungo in
north-east Nigeria has a very slippery problem to deal with. It's infested with
snakes, which are targeting local farmers as they tend their fields and cattle,
as well as children who have gone out to play.
The BBC Hausa service's
Ishaq Khalid has sent these photos through from the town in Gombe state:
Image source: BBC |
A
hospital has been set up nearby which specializes in treating snake bites,
where an average of 12 new cases are reported every day, according to local
health officials:
Image source: BBC |
Image source: BBC |
Snakebite Antidote Is Running Out
The world is running out
of one of the most effective snakebite treatments, putting tens of thousands of
lives at risk, warn experts. Médecins Sans Frontières says new stocks of
Fav-Afrique, which neutralises 10 different snakebites that can occur in
Sub-Saharan Africa, are desperately needed.
The
last batch will expire in June 2016 and there is no comparable replacement.
Manufacturer
Sanofi Pasteur says it has been priced out of the market.
Alternatives
are available but MSF says they are not as good.
Fav-Afrique
is the only anti-venom that has been proven safe and effective to treat
envenoming from different types of snakes across Sub-Saharan Africa, it says.
Sanofi
said it will share the anti-venom recipe with others.
The
company stopped producing the serum last year and has since switched to making
a rabies treatment instead.
Sanofi
is believed to be negotiating for another company to produce Fav-Afrique, but
these talks are not expected to be finalised before late 2016. This means that
a replacement product could not be expected to reach the market for another two
years, says MSF.
The
absence of a broad, safe and effective anti-venom until then will translate
into countless deaths, it says.
Lives at risk
Polly
Markandya of MSF said: "Most people who get bitten by a snake aren't
exactly sure what kind of snake it is that bit them and so having an anti-venom
that works against a variety of different species is really important.
"We
are worried that without that anti-venom available, people will die
unnecessarily."
Alain
Bernal, a Sanofi Pasteur spokesman, said the company had offered to transfer the
anti-venom technology to others, adding: "Nothing has materialized
yet."
The
World Health Organization says snakebites are a neglected issue that needs more
attention and investment.
Each
year, an estimated five million people worldwide are bitten by snakes, out of
whom 100,000 die and 400,000 are permanently disabled or disfigured.
In Sub-Saharan Africa alone, 30,000 people die from snakebite every year and an estimated 8,000 undergo amputations.
In Sub-Saharan Africa alone, 30,000 people die from snakebite every year and an estimated 8,000 undergo amputations.
No comments:
Post a Comment